Researchers have found the injectable weight-loss treatment Ozempic could reduce the risk of heart attacks across the UK.
A study revealed semaglutide, a key ingredient in treatments including Wegovy and Ozempic could likely boost the cardiovascular health of millions.
UK correspondent Enda Brady says it's likely Ozempic will be routinely prescribed in the UK by the end of the decade.
LISTEN ABOVE

Enda Brady: UK correspondent speaks ahead of Trump appearance at NATO summit
03:54

Hamish McKay: The Country spokesperson on the impacts of the rain in Kaikōura
03:25

The Huddle: Should we be worried about China?
09:29